Concepedia

Cost-Effectiveness Analysis of Ranibizumab versus Verteporfin Photodynamic Therapy, Pegaptanib Sodium, and Best Supportive Care for the Treatment of Age-Related Macular Degeneration in Greece

Kostas Athanasakis, V. Fragoulakis, V. Tsiantou, Panagiotis Masaoutis, N Maniadakis, John Kyriopoulos

Clinical Therapeutics · 2012 · 20 citations · 29 references

DOI

Concepts

References

29

Ranibizumab for Neovascular Age-Related Macular Degeneration

Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier et al. · New England Journal of Medicine · 2006 · 5.9K citations · Full text

, , +12

Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration

David M. Brown, Peter K. Kaiser, Mark Michels et al. · New England Journal of Medicine · 2006 · 3.5K citations

, , +13

A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss

Archives of Ophthalmology · 2001 · 3.3K citations · Full text

, , +17

Prevalence of Age-Related Macular Degeneration in the United States

Archives of Ophthalmology · 2004 · 2.7K citations · Full text

, , +15

Pegaptanib for Neovascular Age-Related Macular Degeneration

Evangelos S. Gragoudas, Anthony P. Adamis, Emmett T. Cunningham et al. · New England Journal of Medicine · 2004 · 2.3K citations · Full text

, , +11